Saturday, 31 October 2026European Markets

ASSYSTEM, EUROPRIS, Another 2 Companies Have A High Estimated Dividend Yield

Loading stream...

(vianews) - assystem (asy.pa), europris (epr.ol), argan (arg.pa) have the highest dividend yield stocks on this list.

financial asset forward dividend yield updated (est)
assystem (asy.pa) 16.34% 2024-10-27 11:35:56
europris (epr.ol) 4.44% 2024-10-27 11:20:38
argan (arg.pa) 4.07% 2024-10-27 11:35:48
laurent-perrier (lpe.pa) 2.07% 2024-10-27 11:49:59

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. assystem (asy.pa)

16.34% foward dividend yield

assystem's last close was €47.25, 22.79% under its 52-week high of €61.20. intraday change was 0.42%.

earnings per share

as for profitability, assystem has a trailing twelve months eps of €6.79.

pe ratio

assystem has a trailing twelve months price to earnings ratio of 6.99. meaning, the purchaser of the share is investing €6.99 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.25%.

volume

today's last reported volume for assystem is 5573 which is 57.01% below its average volume of 12966.

yearly top and bottom value

assystem's stock is valued at €47.45 at 21:50 est, way under its 52-week high of €61.20 and way above its 52-week low of €37.20.

more news about assystem.

2. europris (epr.ol)

4.44% foward dividend yield

europris's last close was kr69.05, 11.13% below its 52-week high of kr77.70. intraday change was -0.58%.

earnings per share

as for profitability, europris has a trailing twelve months eps of kr5.53.

pe ratio

europris has a trailing twelve months price to earnings ratio of 12.41. meaning, the purchaser of the share is investing kr12.41 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 33.76%.

volume

today's last reported volume for europris is 80419 which is 43.79% below its average volume of 143088.

dividend yield

according to morningstar, inc., the next dividend payment is on apr 21, 2023, the estimated forward annual dividend rate is 2.75 and the estimated forward annual dividend yield is 4.44%.

yearly top and bottom value

europris's stock is valued at kr68.65 at 21:50 est, way under its 52-week high of kr77.70 and way higher than its 52-week low of kr52.30.

more news about europris.

3. argan (arg.pa)

4.07% foward dividend yield

argan's last close was €69.70, 19.05% below its 52-week high of €86.10. intraday change was -0.43%.

earnings per share

as for profitability, argan has a trailing twelve months eps of €4.

pe ratio

argan has a trailing twelve months price to earnings ratio of 17.35. meaning, the purchaser of the share is investing €17.35 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.67%.

revenue growth

year-on-year quarterly revenue growth grew by 7.4%, now sitting on 229.78m for the twelve trailing months.

more news about argan.

4. laurent-perrier (lpe.pa)

2.07% foward dividend yield

laurent-perrier's last close was €99.20, 23.69% below its 52-week high of €130.00. intraday change was 2.12%.

earnings per share

as for profitability, laurent-perrier has a trailing twelve months eps of €10.16.

pe ratio

laurent-perrier has a trailing twelve months price to earnings ratio of 11.86. meaning, the purchaser of the share is investing €11.86 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.15%.

revenue growth

year-on-year quarterly revenue growth grew by 3.8%, now sitting on 312.54m for the twelve trailing months.

yearly top and bottom value

laurent-perrier's stock is valued at €120.50 at 21:50 est, below its 52-week high of €130.00 and way higher than its 52-week low of €99.20.

volume

today's last reported volume for laurent-perrier is 111 which is 81.71% below its average volume of 607.

more news about laurent-perrier.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com